'Monster cell' melanoma with pulmonary metastasis and cyclin D1 amplification

Journal of Cutaneous Pathology

Volumn 40, Issue 1, 2013, Pages 61-65

  Hawryluk, Elena B ^a   Baran, Johanna L ^a   Gerami, Pedram ^b   Sepehr, Alireza ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cyclin d1; FISH; melanoma; metastasis; monster cells

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1;

ARTICLE; CASE REPORT; FATALITY; FEMALE; GENETICS; GIANT CELL; HUMAN; LUNG TUMOR; MELANOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SKIN TUMOR;

CYCLIN D1; FATAL OUTCOME; FEMALE; GIANT CELLS; HUMANS; LUNG NEOPLASMS; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

MLCS; MLOWN;

EID: 84872872067     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12024     Document Type: Article

References (27)

1. Tamada S, Ackerman AB,. Dermatofibroma with monster cells. Am J Dermatopathol 1987; 9: 380.
2. Goodman WT, Bang RH, Padilla RS,. Giant dermatofibroma with monster cells. Am J Dermatopathol 2002; 24: 36.
3. Rudolph P, Schubert C, Zelger BG, Zelger B, Parwaresch R,. Differential expression of CD34 and Ki-M1p in pleomorphic fibroma and dermatofibroma with monster cells. Am J Dermatopathol 1999; 21: 414.
4. Setoyama M, Fukumaru S, Kanzaki T,. Case of dermatofibroma with monster cells: a review and an immunohistochemical study. Am J Dermatopathol 1997; 19: 312.
5. Defty CL, Segen J, Carter JJ, Ahmed I, Carr RA,. Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cell carcinoma. J Cutan Pathol 2010; 38: 354.
6. Elston DM, Bergfeld WF, Petroff N,. Basal cell carcinoma with monster cells. J Cutan Pathol 1993; 20: 70.
7. Boyd AS, Wu H, Shyr Y,. Monster cells in malignant melanoma. Am J Dermatopathol 2005; 27: 208.
8. Brat DJ, Giannini C, Scheithauer BW, Burger PC,. Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 1999; 23: 745.
9. Bar H, Schlote W,. Malignant melanoma in the CNS, subtyping and immunocytochemistry. Clin Neuropathol 1997; 16: 337.
10. Bongiorno MR, Arico M,. Primary malignant melanoma of the oral cavity: case report. Int J Dermatol 2002; 41: 178.
11. Regauer S, Anderhuber W, Richtig E, Schachenreiter J, Ott A, Beham A,. Primary mucosal melanomas of the nasal cavity and paranasal sinuses. A clinicopathological analysis of 14 cases. APMIS 1998; 106: 403.
12. Crawford RI, Tron VA, Ma R, Rivers JK,. Sinonasal malignant melanoma - a clinicopathologic analysis of 18 cases. Melanoma Res 1995; 5: 261.
13. Sidhu HK, Sidhu JS,. Monster cells in malignant melanoma. Am J Dermatopathol 2006; 28: 462.
14. Gerami P, Jewell SS, Pouryazdanparast P, et al. Copy number gains in 11q13 and 8q34 are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn 2011; 13: 352.
15. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009; 33: 1146.
16. Pouryazdanparast P, Newman M, Mafee M, Guitart J, Gerami P,. Malignant melanoma with monster cells showing massive cyclin D1 amplification. Am J Dermatopathol 2009; 31: 402.
17. Coit DG, Andtbacka R, Anker CJ, et al. Melanoma. J Natl Compr Canc Netw 2012; 10: 366.
18. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199.
19. Long GV, Menzies AM, Nagrial AM, et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol 2011; 29: 1239.
20. Molenaar JJ, Koster J, Ebus ME, et al. Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes Chromosomes Cancer 2011; 51: 10.
21. Saridaki Z, Papadatos-Pastos D, Tzardi M, et al. BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome. Br J Cancer 2010; 102: 1762.
22. Roy PG, Pratt N, Purdie CA, et al. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Cancer 2009; 127: 355.
23. Cao W, Liu Y, Zhang H, Wang S, Zhang L, Sun B,. Expression of LMP-1 and Cyclin D1 protein is correlated with an unfavorable prognosis in nasal type NK/T cell lymphoma. Mol Med Report 2008; 1: 363.
24. Chang MC, Chang YT, Sun CT, Chiu YF, Lin JT, Tien YW,. Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater. World J Surg 2007; 31: 1135.
25. Gammon B, Ali L, Guitart J, Gerami P,. Homogeneous staining regions for cyclin d1, a marker of poor prognosis in malignant melanoma. Am J Dermatopathol 2012; 34: 487.
26. Tuncer E, Turk NS, Arici S, Duzcan SE, Demirkan NC,. Expression of p16 protein and cyclin D1 in periampullary carcinomas. Turk Patoloji Derg 2011; 27: 17.
27. Zhang LQ, Jiang F, Xu L, et al. The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis. Clin Lung Cancer 2012; 13: 188.